In contrast to traditional TVN strategy by AAT, we propose a new strategy to fortify the TVN effect, which may be an alternative to fill gaps in current TVN strategies and provide preliminary enlightenment to design a versatile nanoparticle co-targeting VEGF and PFKF3 for normalizing tumor microenvironment persistently. The gene discussed is VEGFA; the disease is neoplasm.